Share Name Share Symbol Market Type Share ISIN Share Description
Genus Plc LSE:GNS London Ordinary Share GB0002074580 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 3,744.00 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
3,738.00 3,742.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 551.40 51.50 62.40 60.0 2,437
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 3,744.00 GBX

Genus (GNS) Latest News

More Genus News
Genus Takeover Rumours
Smart Money!
GNS is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 

Genus (GNS) Discussions and Chat

Genus Forums and Chat

Date Time Title Posts
08/9/202015:21Genus with Charts172
25/5/200517:54BEEF UP THAT MACHO GENUS43
25/9/200200:06Genus - these todger tuggers are flying3
02/9/200219:43Is this stock very undervalued? - any more info22

Add a New Thread

Genus (GNS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-09-21 16:16:393,744.1998736,955.13O
2020-09-21 16:11:253,773.562057,735.80O
2020-09-21 16:01:093,726.8127610,285.99O
2020-09-21 16:00:563,740.11873,253.90O
2020-09-21 15:53:133,737.5931011,586.53O
View all Genus trades in real-time

Genus (GNS) Top Chat Posts

Genus Daily Update: Genus Plc is listed in the Support Services sector of the London Stock Exchange with ticker GNS. The last closing price for Genus was 3,744p.
Genus Plc has a 4 week average price of 3,292p and a 12 week average price of 3,292p.
The 1 year high share price is 4,056p while the 1 year low share price is currently 2,470p.
There are currently 65,093,780 shares in issue and the average daily traded volume is 140,759 shares. The market capitalisation of Genus Plc is £2,437,111,123.20.
planckfund2: huttonr & clintonville -- certainly the demand for consumer products such as pork will carry on rising in china and the far east baring disaster --- it's just that the share price rise of genus has really been excessive and more to do with selling the story than the fact, and extreme supply constraints and I'm grateful for that: but this type of demand always means boom and bust -- there is no middle way --- so i think the sell off will probably continue very sharply for a good while - this doesn't mean that they aren't a good company and that there isn't a market for their excellent products. I won't go short because i'm a coward but as things stand i will leave it a while before reevaluating. Good luck!
huttonr: A few comments - partly to see what other people think. It seems to me that the share price got a bit ahead of itself during the last month or so and we have now got back to a reasonable level. Looking at the rise since January, we have had a good run and hopefully will stay around this level for a while. The so-called Chinese slowdown looks more like a little reduction in the growth rate but the real change in demand for meat in China - pork especially - seems likely to continue as the pace of social change continues. The company appears to be doing the right things with their current emphasis on China which will make up for a possible mild slowdown elsewhere. However, the basic selling point for Genus is the yield improvement and they do seem to be one of the market leaders here.
northernlass: What The Analysts Say MORGAN STANLEY SAYS... Overweight. Our bull case valuation - at 1,790p - assumes that Genus meets its aspirational earnings growth target of 15 per cent year on year throughout the decade. But there are strong global themes to drive that thesis. These include population growth and rising food demand, industrialised farming methods and sector consolidation among food producers, as well as emerging markets growth, coupled with a shift there towards western-style diets - that is, more dairy and meat consumption. Expect EPS to rise to 52p for the year to end-June 2012, from 44.1p in 2011. PEEL HUNT SAYS... Buy. The share price rating does look full, but the longer-term growth opportunity remains compelling. Genus is the global market leader in this business and is increasing its competitive advantage. In fact, the company boasts a number of strategic advantages, such as its genetic lead and international presence. Moreover, research and development initiatives provide the opportunity for step-changes in market share and profitability. Genus looks increasingly well positioned to take advantage of growth opportunities. The price target stands at 1,500p and expect adjusted EPS for end-June 2012 of 50.8p. Read the full article here: P.S. Here's a couple of links about SCLP, one of the hottest stocks at the moment:
cellars: I think the growth outlook does not justify the current high valuation of the shares. I assume current fx rates will prevail throughout H2 FY09 and all of FY10. Also that H1 FY09 margins are sustainable but will not grow. This points to EPS of about 42p for FY10 and the following 5 year earnings growth at about 11% pa (opportunities in China etc). This leaves the share price looking expensive even for a trade buyer.
mdchand: debt has moved by -20m yet the share price has moved about -50m. Seems an over-reaction to me, especially if there debt is linked to US libor rates which means a very low interest cost moving forward. Still, strip out the fx movements and you have 1% growth - which is probably concerning the markets more right now. Looks like a nice short term trade for some.
dvarty: 2001 outbreak had an imense impact- the share price hit the floor and their profits took a hit. If I remember correctly the share price was sub 120. The price today opened 10p down and i would expect a further slide over the next 2 weeks.
greenslug: would you buy in a placing that close to the open market share price? I wouldn't and even at 325 the discount isn't that great and maybe even less in due course!
greatbear: Comment below from the Sunday Express. Genus (GNS.L) - a sound balance sheet and good cash flow is not fully reflected in 171p share price.
greatbear: H E Wents, Definitly not!! I think there is a 30% fair growth in it's share price over the next 12 months. Ie target of 230p.
Genus share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200922 06:02:02